Canadian CANNAINVESTOR Magazine June / July 2018 | Page 71

Here are some

quick relevant

facts with links:

Greg Engel discusses Quarterly results with James West – note the reference to their proprietary software and how that and other measures have allowed them to achieve results of 400 grams per square foot per year. CLICK HERE

On May 15th, Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada (AKA “Dealer’s License). CLICK HERE

Also on May 15th, Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands.

CLICK HERE

Organigram Receives Permit to Export Medical Cannabis to Australia.

CLICK HERE

Organigram appoints VP, International Business Development, prepares for international growth. CLICK HERE

Organigram Invests $3.8-Million In German Cannabis Company.

CLICK HERE

For just over two years now we have been reminding our audience (investors, companies, politicians, and industry leaders) of the importance of Hemp and how that industry will dwarf the legal cannabis industry. Om June 4th, OGI announced that it had entered a non-binding LOI to make a $10M investment in European Hemp producer Eviana Health Corporation (CSE:EHC). CLICK HERE. EHC is also a case study this month.

Lastly, Health Canada on June 5th approved Organigram’s Phase 3 expansion. CLICK HERE

71

whether it be in health, animal care, food and nutrition, textiles, building materials, plastics and other substitutes, etc. Imagine when science can definitively prove cannabis as an effective treatment for just one medical condition. Now imagine two … now three … now four. Organigram is a success. Organigram is forward thinking. They are entrepreneurial and visionary. They have imagination and they know what this technology would mean to R&D as well as to commercial and consumer applications. Imagine being able to create targeted levels of THC and CBD in days not weeks or months and without the space and cost/resource requirements of traditional growing. The LOI at time of writing is non-binding as it subject to further due diligence and other procedural matters before it advances, but it demonstrates that OGI has the will to be at the forefront of game-changing technology that could transform the industry.